Survival analysis of malignant tumors in cancer registration areas of Hubei province in China, 2013 to 2015.
10.3760/cma.j.cn112152-20230403-00145
- Author:
Shuang YAO
1
;
Bin XIONG
2
;
Ji Yu TUO
1
;
Yu QIN
1
;
Fan Di MENG
1
;
Ya Fen XIA
1
;
Min ZHANG
1
;
Shao Zhong WEI
3
Author Information
1. Hubei Cancer Registration Center, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430079, China.
2. Wufeng Tujia Autonomous County Center for Disease Control and Prevention, Yichang 443413, China.
3. Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei Colorectal Cancer Clinical Medical Research Center, Wuhan Colorectal Cancer Clinical Medical Research Center, Wuhan 430079, China.
- Publication Type:Journal Article
- Keywords:
Cancer registration;
Neoplasms;
Observed survival rate;
Relative survival rate
- MeSH:
Humans;
Female;
Male;
Liver Neoplasms;
Uterine Cervical Neoplasms/epidemiology*;
Lung Neoplasms;
China/epidemiology*;
Urban Population;
Incidence;
Survival Analysis;
Rural Population;
Registries
- From:
Chinese Journal of Oncology
2023;45(12):1051-1056
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To analyze the survival of newly diagnosed malignant tumors in cancer registration areas of Hubei Province from 2013 to 2015. Methods: From January 1, 2013 to December 31, 2015, all newly diagnosed malignant tumors were collected from cancer registration areas in Hubei Province, and patients were followed up using a combination of active and passive methods. Cancer survival was analyzed using the strs package in Stata software. Observed and expected survival were calculated using the life table and Ederer Ⅱ methods, and the difference in survival rate of patients with different sex, age, urban and rural areas and different cancer species was compared. Results: From 2013 to 2015, 83 987 new malignant tumors were diagnosed in cancer registration areas in Hubei Province, including 45 742 males (54.46%) and 38245 females (45.54%). The overall 5-year relative survival rate was 41.46%, 34.43% for men and 49.63% for women. With the increase of age, the observed survival rate and relative survival rate of patients of different genders showed a decreasing trend. The 5-year relative survival rate of patients with malignant tumors was 47.58% in urban areas and 26.58% in rural areas. The observed survival rate and relative survival rate in rural areas were significantly lower than those in urban areas. The overall 5-year relative survival rates for common malignancies were 20.61% for lung cancer, 15.36% for liver cancer, 22.89% for esophageal cancer, 34.92% for gastric cancer, and 54.87% for colorectal cancer. In addition, the 5-year relative survival rates of common malignant tumors in women were 78.65% for breast cancer and 52.55% for cervical cancer. Conclusions: In Hubei Province, the survival rate of malignant tumors is different among different genders, regions, age groups and cancer species. Prevention and treatment and health education should be strengthened for malignant tumor patients in rural areas and those with high incidence and low survival rate such as liver cancer and lung cancer, and relevant strategies should be formulated according to the gender and age distribution characteristics of different cancer species.
